Stocks and Investing Stocks and Investing
Wed, August 9, 2023

Andrew Fein Reiterated (SYRS) at Strong Buy and Held Target at $15 on, Aug 9th, 2023


Published on 2024-10-28 05:43:25 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Reiterated "Syros Pharmaceuticals, Inc." (SYRS) at Strong Buy and Held Target at $15 on, Aug 9th, 2023.

Andrew has made no other calls on SYRS in the last 4 months.



There is 1 other peer that has a rating on SYRS. Out of the 1 peers that are also analyzing SYRS, 0 agree with Andrew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Andrew


  • Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $15 on, Thursday, May 11th, 2023
Contributing Sources